Effectively limit supply bottlenecks for medicines and reduce the dependence of medicine supplies on non-EU countries

Summary

Presentation of a bill: Obligation for pharmaceutical companies to report if a prescription drug is unavailable for more than two weeks and in this regard. Export ban, change in the awarding of discount contracts in accordance with SGB V: Awarding of contracts to at least two different providers, guaranteeing the production of both the finished medicinal product and the active ingredient within the EU through at least one of these providers

Machine translation from German. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• 19/15789

  Drucksache · DE · 11 December 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.